Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 13.87 million. The enterprise value is 11.90 million.
| Market Cap | 13.87M |
| Enterprise Value | 11.90M |
Important Dates
The last earnings date was Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.34 million shares outstanding. The number of shares has increased by 22.44% in one year.
| Current Share Class | 13.84M |
| Shares Outstanding | 17.34M |
| Shares Change (YoY) | +22.44% |
| Shares Change (QoQ) | +6.03% |
| Owned by Insiders (%) | 38.71% |
| Owned by Institutions (%) | n/a |
| Float | 6.81M |
Valuation Ratios
The trailing PE ratio is 74.96.
| PE Ratio | 74.96 |
| Forward PE | n/a |
| PS Ratio | 1.71 |
| PB Ratio | 5.27 |
| P/TBV Ratio | 5.27 |
| P/FCF Ratio | 126.59 |
| P/OCF Ratio | 126.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.39, with an EV/FCF ratio of 108.57.
| EV / Earnings | 90.99 |
| EV / Sales | 1.47 |
| EV / EBITDA | 69.39 |
| EV / EBIT | 159.22 |
| EV / FCF | 108.57 |
Financial Position
The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.13 |
| Quick Ratio | 3.00 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 1.36 |
| Interest Coverage | 6.88 |
Financial Efficiency
Return on equity (ROE) is 5.18% and return on invested capital (ROIC) is 1.76%.
| Return on Equity (ROE) | 5.18% |
| Return on Assets (ROA) | 1.28% |
| Return on Invested Capital (ROIC) | 1.76% |
| Return on Capital Employed (ROCE) | 2.84% |
| Weighted Average Cost of Capital (WACC) | 22.42% |
| Revenue Per Employee | 126,405 |
| Profits Per Employee | 2,043 |
| Employee Count | 89 |
| Asset Turnover | 2.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +742.11% in the last 52 weeks. The beta is 3.34, so Syra Health's price volatility has been higher than the market average.
| Beta (5Y) | 3.34 |
| 52-Week Price Change | +742.11% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 0.35 |
| Relative Strength Index (RSI) | 52.09 |
| Average Volume (20 Days) | 22,648 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 9.14 |
Income Statement
In the last 12 months, Syra Health had revenue of 8.09 million and earned 130,749 in profits. Earnings per share was 0.01.
| Revenue | 8.09M |
| Gross Profit | 3.18M |
| Operating Income | 74,722 |
| Pretax Income | 130,749 |
| Net Income | 130,749 |
| EBITDA | 87,970 |
| EBIT | 74,722 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 2.12 million in cash and 149,338 in debt, with a net cash position of 1.97 million or 0.11 per share.
| Cash & Cash Equivalents | 2.12M |
| Total Debt | 149,338 |
| Net Cash | 1.97M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 2.63M |
| Book Value Per Share | 0.15 |
| Working Capital | 2.55M |
Cash Flow
In the last 12 months, operating cash flow was 109,683 and capital expenditures -107, giving a free cash flow of 109,576.
| Operating Cash Flow | 109,683 |
| Capital Expenditures | -107 |
| Depreciation & Amortization | 13,248 |
| Net Borrowing | -291,753 |
| Free Cash Flow | 109,576 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 39.35%, with operating and profit margins of 0.92% and 1.62%.
| Gross Margin | 39.35% |
| Operating Margin | 0.92% |
| Pretax Margin | 1.62% |
| Profit Margin | 1.62% |
| EBITDA Margin | 1.09% |
| EBIT Margin | 0.92% |
| FCF Margin | 1.35% |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.44% |
| Shareholder Yield | -22.44% |
| Earnings Yield | 0.94% |
| FCF Yield | 0.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Syra Health has an Altman Z-Score of 1.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.24 |
| Piotroski F-Score | 4 |